http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI9911178-B8
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e673458c8c443e6fcd34bbc9565bf7f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00 |
| filingDate | 1999-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f43f94ef9f14eb540e1d3b935a10ec3b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c96f0ea58e00027c33ce72dc24619e6e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54e65588fdde58f464676d848d224a75 |
| publicationDate | 2017-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI9911178-B8 |
| titleOfInvention | 3- (2-oxo- [1,3 '] bipyrrolidinyl-3-ylidenemethyl) -femor derivatives, as well as pharmaceutical preparation and use thereof |
| abstract | "3- (2-oxo- [1,3 '] bipyrrolidinyl-3-ylidenemethyl) -febs derivatives" <d>. The present invention relates to novel compounds of formula (I) wherein R 14 is hydrogen, C 1-6 alkyl, optionally substituted by fluorine, or C 3-6 cycloalkyl; R 2 is hydrogen or a group selected from -ch ~ 2-c (= chr) -coor, -ch ~ 2-ocor, -ch (r) ocor, -ch (r) ocoor, -ch (ocor) ocor, -cr 2 -coch-2-ocor and (ii); R ^ 3 ^ is hydrogen or group selected from -ch ~ 2 ~ c (= ch ~ 2 ~) -coor, -cooch ~ 2 ~ c (= chr) -coor, -cooch ~ 2-ocor, -cooch (r ) ocor, -cooch (r) ocoor, -cooch (ocor) ocor, -cooch-2-coch-2-ocor, and (iii); provided that one of r ^ 2 ^ and r ^ 3 ^ is hydrogen and the other of r ^ 2 ^ and r ^ 3 ^ is different from hydrogen, r is hydrogen or C 1-6 -alkyl; R4 is hydrogen or hydroxy; R5 is hydrogen or hydroxyalkyl; ex is ch or n, as well as to pharmaceutically acceptable salts of said compounds and hydrates of said compounds and their salts, and to the use of compounds of formula (i) and pharmaceutically acceptable salts of said compounds and hydrates of said compounds and salts thereof for the manufacture of pharmaceutical preparations containing such compounds. |
| priorityDate | 1998-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.